rentradВестник рентгенологии и радиологииJournal of radiology and nuclear medicine0042-46762619-0478Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists10.20862/0042-4676-2021-102-3-183-195rentrad-650Research ArticleОБЗОРЫREVIEWSКТ-диагностика осложнений, возникающих при естественном течении и терапии COVID-19CT Diagnosis of Complications Arising from the Natural History and Treatment of COVID-19https://orcid.org/0000-0002-2566-9881ЯдренцеваС. В.YadrentsevaS. V.

Ядренцева Светлана Владимировна, кандидат медицинских наук, врач-рентгенолог отделения лучевой диагностики ФГБУ «Клиническая больница № 1» Управления делами Президента Российской Федерации, врач-рентгенолог консультативного отдела ГБУЗ «Научно-практический клинический центр диагностики и телемедицинских технологий» Департамента здравоохранения г. Москвы

ул. Староволынская, 10, Москва, 121352,

ул. Средняя Калитниковская, 28, стр. 1, Москва, 109029

Svetlana V. Yadrentseva, Cand. Med. Sc., Radiologist, Radiology Department, Clinical Hospital No. 1, Office of the President of the Russian Federation; Radiologist, Advisory Department, Scientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies

ul. Starovolynskaya, 10, Moscow, 121352,

ul. Srednyaya Kalitnikovskaya, 28 bld. 1, Moscow, 109029

sv.yadrentseva@gmail.comhttps://orcid.org/0000-0001-5994-0468НудновН. В.NudnovN. V.

Нуднов Николай Васильевич, доктор медицинских наук, профессор, заместитель директора по научной работе

ул. Профсоюзная, 86, стр. 1, Москва, 117997

Nikolay V. Nudnov, Dr. Med. Sc., Professor, Deputy Director for Research

ul. Profsoyuznaya, 86 bld. 1, Moscow, 117997

https://orcid.org/0000-0001-6430-9590ГасымовЭ. Г.GasymovE. G.

Гасымов Эмиль Гадирович, врач-ординатор

ул. Маршала Тимошенко, 19, стр. 1А, Москва, 121359

Emil’ G. Gasymov, Resident Physician

ul. Marshala Timoshenko, 19 bld. 1A, Moscow, 121359

https://orcid.org/0000-0003-0531-7966ПронькинаЕ. В.Pron’kinaE. V.

Пронькина Елена Владимировна, врач-рентгенолог

пер. Сивцев Вражек, 26/28, Москва, 119002

Elena V. Pron’kina, Radiologist

pereulok Sivtsev Vrazhek, 26/28, Moscow, 119002

ФГБУ «Клиническая больница № 1» Управления делами Президента Российской Федерации; ГБУЗ «Научно-практический клинический центр диагностики и телемедицинских технологий» Департамента здравоохранения г. МосквыРоссияClinical Hospital No. 1, Office of the President of the Russian Federation; Scientific and Practical Clinical Center for Diagnostics and Telemedicine TechnologiesRussian FederationФГБУ «Российский научный центр рентгенорадиологии» Минздрава РоссииРоссияRussian Scientific Center of RadiologyRussian FederationФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской ФедерацииРоссияCentral State Medical Academy, Office of the President of the Russian FederationRussian FederationФГБУ «Поликлиника № 1» Управления делами Президента Российской ФедерацииРоссияPolyclinic No. 1, Office of the President of the Russian FederationRussian Federation2021230720211023183195Copyright © Ядренцева С.В., Нуднов Н.В., Гасымов Э.Г., Пронькина Е.В., 20212021Ядренцева С.В., Нуднов Н.В., Гасымов Э.Г., Пронькина Е.В.Yadrentseva S.V., Nudnov N.V., Gasymov E.G., Pron’kina E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.russianradiology.ru/jour/article/view/650

Компьютерная томография при коронавирусной инфекции (COVID-19) эффективна не только в постановке диагноза, но и в своевременном и точном выявлении некоторых осложнений данного заболевания со стороны различных органов и систем. В статье показаны осложнения коронавирусной инфекции, с которыми может столкнуться на практике врач-рентгенолог. Они развиваются как при естественном течении, так и вследствие терапии COVID-19, включая геморрагические и тромботические осложнения при коагулопатии, пневмоторакс и пневмомедиастинум как следствие прямого цитотоксического действия SARS-CoV-2 на пневмоциты, баротравмы при искусственной вентиляции легких, а также патологические переломы ввиду остеопороза, в том числе стероидного, развившегося на фоне терапии глюкокортикостероидами. Рассмотрены основные причины, патогенез различных осложнений коронавирусной инфекции.

Computed tomography for coronavirus infection (COVID-19) is effective not only in making a diagnosis, but also in timely and accurately detecting some complications of this disease in different organs and systems. The paper shows various complications of coronavirus infection that a radiologist may face in practice, which develop both in the natural course and due to therapy for COVID-19, including hemorrhagic and thrombotic events in coagulopathy, pneumothorax, and pneumomediastinum as a result of the direct cytotoxic effect of SARS-CoV-2 on pneumocytes, and barotrauma during mechanical ventilation, as well as pathological fractures due to osteoporosis, including steroid osteoporosis that has developed during therapy with glucocorticosteroids. It considers the main causes and pathogenesis of various complications of coronavirus infection.

коронавирусная инфекцияCOVID-19компьютерная томографиятромбоэмболия легочной артериипневмоторакспневмомедиастинумгеморрагические осложнениятромботические осложненияобзорcoronavirus infectionCOVID-19computed tomographypulmonary embolismpneumothoraxpneumomediastinumhemorrhagic eventsthrombotic eventsreviewReferencesXu B, Xing Y, Peng J, et al. Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy. Eur Radiol. 2020; 30(10): 5720–7. https://doi.org/10.1007/s00330-020-06934-2.Xu B, Xing Y, Peng J, et al. Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy. Eur Radiol. 2020; 30(10): 5720–7. https://doi.org/10.1007/s00330-020-06934-2.Винокуров А.С., Беленькая О.И., Золотова Е.А. и др. Дифференциальная диагностика двусторонних изменений легких на опыте стационара по приему внебольничных пневмоний – не только COVID-19. Медицинская визуализация. 2020; 24(2): 78–95. https://doi.org/10.24835/1607-0763-2020-2-78-95.Vinokurov AS, Belenkaya OI, Zolotova EA, et al. Differential diagnosis of bilateral lungs opacities in the hospital for admission of community-acquired pneumonia – not only COVID-19. Medical Visualization. 2020; 24(2): 78–95 (in Russ.). https://doi.org/10.24835/1607-0763-2020-2-78-95.Баринов В.Е., Бояринцев В.В. Венозные тромботические осложнения как спутник новой короновирусной инфекции COVID-19. Кремлевская медицина. Клинический вестник. 2020; 2: 22–7. https://doi.org/10.26269/ayxs-2p77.Barinov VE, Boyarintsev VV. Venous thrombotic complications as a satellite of the new coronavirus infection COVID-19. Kremlin Medical Journal. 2020; 2: 22–7 (in Russ.). https://doi.org/10.26269/ayxs-2p77.Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care. 2020; 24(1): 198. https://doi.org/10.1186/s13054-020-02911-9.Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care. 2020; 24(1): 198. https://doi.org/10.1186/s13054-020-02911-9.Колов И.А, Тюрин И.Н. Сердечно-сосудистые осложнения COVID-19. Вестник анестезиологии и реаниматологии. 2020; 17(4): 14–22. https://doi.org/10.21292/2078-5658-2020-17-4-14-22.Kozlov IA, Tyurin IN. Cardiovascular complications of COVID-19. Messenger of Anesthesiology and Resuscitation. 2020; 17(4): 14–22 (in Russ.). https://doi.org/10.21292/2078-5658-2020-17-4-14-22.Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26(7): 1017–32. https://doi.org/10.1038/s41591-020-0968-3.Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26(7): 1017–32. https://doi.org/10.1038/s41591-020-0968-3.Klok FA, Kruip MJ, Meer NJ, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145–7. https://doi.org/10.1016/j.thromres.2020.04.013.Klok FA, Kruip MJ, Meer NJ, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145–7. https://doi.org/10.1016/j.thromres.2020.04.013.Klok FA, Kruip MJ, Meer NJ, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020; 191: 148–50. https://doi.org/10.1016/j.thromres.2020.04.041.Klok FA, Kruip MJ, Meer NJ, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020; 191: 148–50. https://doi.org/10.1016/j.thromres.2020.04.041.Haimei MA. Pathogenesis and treatment strategies of COVID-19-related hypercoagulant and thrombotic complications. Clin Appl Thromb Hemost. 2020; 26: 1076029620944497. https://doi.org/10.1177/1076029620944497.Haimei MA. Pathogenesis and treatment strategies of COVID-19-related hypercoagulant and thrombotic complications. Clin Appl Thromb Hemost. 2020; 26: 1076029620944497. https://doi.org/10.1177/1076029620944497.Magrone T, Magrone M, Jirillo E. Focus on receptors for coronaviruses with special reference to angiotensin – converting enzyme 2 as a potential drug target – a perspective. Endocr Metab Immune Disord Drug Targets. 2020; 20(6): 807–11. https://doi.org/10.2174/1871530320666200427112902.Magrone T, Magrone M, Jirillo E. Focus on receptors for coronaviruses with special reference to angiotensin – converting enzyme 2 as a potential drug target – a perspective. Endocr Metab Immune Disord Drug Targets. 2020; 20(6): 807–11. https://doi.org/10.2174/1871530320666200427112902.Mogielnicki A, Kramkowski K, Hermanowicz JM, et al. Angiotensin-(1-9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis. J Renin Angiotensin Aldosterone Syst. 2014; 15(1): 13–21. https://doi.org/10.1177/1470320313498631.Mogielnicki A, Kramkowski K, Hermanowicz JM, et al. Angiotensin-(1-9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis. J Renin Angiotensin Aldosterone Syst. 2014; 15(1): 13–21. https://doi.org/10.1177/1470320313498631.Chan NC, Weitz JI. COVID-19 coagulopathy, thrombosis, and bleeding. Blood. 2020; 136(4): 381–3. https://doi.org/10.1182/blood.2020007335.Chan NC, Weitz JI. COVID-19 coagulopathy, thrombosis, and bleeding. Blood. 2020; 136(4): 381–3. https://doi.org/10.1182/blood.2020007335.Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020; 383(2):120–8. https://doi.org/10.1056/NEJMoa2015432.Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020; 383(2):120–8. https://doi.org/10.1056/NEJMoa2015432.Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020; 126(10): 1456–74. https://doi.org/10.1161/CIRCRESAHA.120.317015.Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020; 126(10): 1456–74. https://doi.org/10.1161/CIRCRESAHA.120.317015.Bompard F, Monnier H, Saab I, et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020; 56(1): 2001365. https://doi.org/10.1183/13993003.01365-2020.Bompard F, Monnier H, Saab I, et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020; 56(1): 2001365. https://doi.org/10.1183/13993003.01365-2020.Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020; 18(8): 1859–65. https://doi.org/10.1111/jth.14929.Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020; 18(8): 1859–65. https://doi.org/10.1111/jth.14929.Yamakawa M, Kuno T, Mikami T, et al. Clinical characteristics of stroke with COVID-19: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020; 29(12): 105288. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105288.Yamakawa M, Kuno T, Mikami T, et al. Clinical characteristics of stroke with COVID-19: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020; 29(12): 105288. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105288.Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020; 142(2): 184–6. https://doi.org/10.1161/CIRCULATIONAHA.120.047430.Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020; 142(2): 184–6. https://doi.org/10.1161/CIRCULATIONAHA.120.047430.Pryce-Roberts A, Talaei M, Robertson NP. Neurological complications of COVID-19: a preliminary review. J Neurol. 2020; 267(6): 1870–13. https://doi.org/10.1007/s00415-020-09941-x.Pryce-Roberts A, Talaei M, Robertson NP. Neurological complications of COVID-19: a preliminary review. J Neurol. 2020; 267(6): 1870–13. https://doi.org/10.1007/s00415-020-09941-x.Hanff TC, Mohareb AM, Giri J, et al. Thrombosis in COVID-19. Am J Hematol. 2020; 95(12): 1578–89. https://doi.org/10.1002/ajh.25982.Hanff TC, Mohareb AM, Giri J, et al. Thrombosis in COVID-19. Am J Hematol. 2020; 95(12): 1578–89. https://doi.org/10.1002/ajh.25982.Mao L, Jin H, Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683–90. https://doi.org/10.1001/jamaneurol.2020.1127.Mao L, Jin H, Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683–90. https://doi.org/10.1001/jamaneurol.2020.1127.Dorgalaleh A. Bleeding and bleeding risk in COVID-19. Semin Thromb Hemost. 2020; 46(7): 815–8. https://doi.org/10.1055/s-0040-1713434.Dorgalaleh A. Bleeding and bleeding risk in COVID-19. Semin Thromb Hemost. 2020; 46(7): 815–8. https://doi.org/10.1055/s-0040-1713434.Kumar A, Arora A, Sharma P, et al. Clinical features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. SSRN. 2020; 3566166. https://doi.org/10.2139/ssrn.3566166.Kumar A, Arora A, Sharma P, et al. Clinical features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. SSRN. 2020; 3566166. https://doi.org/10.2139/ssrn.3566166.Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 cases of death with COVID-19. PLoS One. 2020; 15(7): e0235458. https://doi.org/10.1371/journal.pone.0235458.Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 cases of death with COVID-19. PLoS One. 2020; 15(7): e0235458. https://doi.org/10.1371/journal.pone.0235458.Liu X, Zhang X, Xiao Y, et al. Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment. MedRxiv. 2020. https://doi.org/10.1101/2020.04.23.20076851.Liu X, Zhang X, Xiao Y, et al. Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment. MedRxiv. 2020. https://doi.org/10.1101/2020.04.23.20076851.Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5): 475–81. https://doi.org/10.1016/S2213-2600(20)30079-5.Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5): 475–81. https://doi.org/10.1016/S2213-2600(20)30079-5.Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol. 2020; 76(16): 1815–26. https://doi.org/10.1016/j.jacc.2020.08.041.Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol. 2020; 76(16): 1815–26. https://doi.org/10.1016/j.jacc.2020.08.041.Quincho-Lopez A, Quincho-Lopez DL, Hurtado-Medina FD. Case report: pneumothorax and pneumomediastinum as uncommon complications of COVID-19 pneumonia-literature review. Am J Trop Med Hyg. 2020; 103(3): 1170–6. https://doi.org/10.4269/ajtmh.20-0815.Quincho-Lopez A, Quincho-Lopez DL, Hurtado-Medina FD. Case report: pneumothorax and pneumomediastinum as uncommon complications of COVID-19 pneumonia-literature review. Am J Trop Med Hyg. 2020; 103(3): 1170–6. https://doi.org/10.4269/ajtmh.20-0815.Михеев А.В., Афтаева Е.В., Казакова С.С. и др. Спонтанный пневмоторакс как осложнение поражения легких при COVID-19. Туберкулез и болезни легких. 2021; 99(3): 18–22. https://doi.org/10.21292/2075-1230-2021-99-3-18-22.Mikheev AV, Аftаevа EV, Kаzаkovа SS, et al. Spontaneous pneumothorax as a complication of lung injury due to COVID-19. Tuberculosis and Lung Diseases. 2021; 99(3): 18–22 (in Russ.). https://doi.org/10.21292/2075-1230-2021-99-3-18-22.Diaz R, Heller D. Barotrauma and mechanical ventilation. Treasure Island (FL): StatPearls Publishing; 2021.Diaz R, Heller D. Barotrauma and mechanical ventilation. Treasure Island (FL): StatPearls Publishing; 2021.Kolani S, Houari N, Haloua M, et al. Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection. IDCases. 2020; 21: e00806. https://doi.org/10.1016/j.idcr.2020.e00806.Kolani S, Houari N, Haloua M, et al. Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection. IDCases. 2020; 21: e00806. https://doi.org/10.1016/j.idcr.2020.e00806.McGuinness G, Zhan C, Rosenberg N, et al. Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology. 2020; 297(2): 252–62. https://doi.org/10.1148/radiol.2020202352.McGuinness G, Zhan C, Rosenberg N, et al. Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology. 2020; 297(2): 252–62. https://doi.org/10.1148/radiol.2020202352.Lemmers DH, Hilal MA, Bna C, et al. Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty? ERJ Open Res. 2020; 6(4): 00385-2020. https://doi.org/10.1183/23120541.003852020.Lemmers DH, Hilal MA, Bna C, et al. Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty? ERJ Open Res. 2020; 6(4): 00385-2020. https://doi.org/10.1183/23120541.003852020.Yu EW, Tsourdi E, Clarke BL, et al. Osteoporosis management in the era of COVID-19. J Bone Miner Res. 2020; 35(6): 1009–13. https://doi.org/10.1002/jbmr.4049.Yu EW, Tsourdi E, Clarke BL, et al. Osteoporosis management in the era of COVID-19. J Bone Miner Res. 2020; 35(6): 1009–13. https://doi.org/10.1002/jbmr.4049.Tramontana F, Napoli N, Fuleihan GE, Strollo R. The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond. Endocrine. 2020; 69(2): 237–40. https://doi.org/10.1007/s12020-020-02407-0.Tramontana F, Napoli N, Fuleihan GE, Strollo R. The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond. Endocrine. 2020; 69(2): 237–40. https://doi.org/10.1007/s12020-020-02407-0.Kortebein P, Ferrando A, Lombeida J, et al. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007; 297(16): 1772–4. https://doi.org/10.1001/jama.297.16.1772-b.Kortebein P, Ferrando A, Lombeida J, et al. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007; 297(16): 1772–4. https://doi.org/10.1001/jama.297.16.1772-b.Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009; 29(5): 555–67. https://doi.org/10.1007/s10875-009-9316-6.Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009; 29(5): 555–67. https://doi.org/10.1007/s10875-009-9316-6.Mikulska M, Nicolini LA, Signori A, et al. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. PLoS One. 2020; 15(8): e0237831. https://doi.org/10.1371/journal.pone.0237831.Mikulska M, Nicolini LA, Signori A, et al. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. PLoS One. 2020; 15(8): e0237831. https://doi.org/10.1371/journal.pone.0237831.Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect. 2020; 53(3): 436–43. https://doi.org/10.1016/j.jmii.2020.03.034.Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect. 2020; 53(3): 436–43. https://doi.org/10.1016/j.jmii.2020.03.034.Lane NE, Yao W, Balooch M, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebotreated or estrogen-deficient mice. J Bone Miner Res. 2006; 21(3): 466–76. https://doi.org/10.1359/JBMR.051103.Lane NE, Yao W, Balooch M, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebotreated or estrogen-deficient mice. J Bone Miner Res. 2006; 21(3): 466–76. https://doi.org/10.1359/JBMR.051103.

The authors declare that there are no conflicts of interest present.